Shree Swasti Chemipharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-10-2024
- Paid Up Capital ₹ 0.10 M
as on 27-10-2024
- Company Age 3 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
About Shree Swasti Chemipharma
The Corporate was formerly known as Shree Swasthi Chemipharma Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Gandhi, Sandeep Mehta, Jagrut Gandhi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24302MH2022PTC375326
- Company No.
375326
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Swasti Chemipharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samyak Gandhi  | Director | 21-Jan-2022 | Current |
| Atul Gandhi | Director | 21-Jan-2022 | Current |
| Sandeep Mehta | Director | 28-Aug-2023 | Current |
| Jagrut Gandhi | Director | 21-Jan-2022 | Current |
Financial Performance of Shree Swasti Chemipharma.
Shree Swasti Chemipharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shree Swasti Chemipharma?
Unlock access to Shree Swasti Chemipharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sarvoshadhi Chemipharma Private LimitedActive 1 year 2 monthsAtul Gandhi, Jagrut Gandhi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shree Swasti Chemipharma?
Shree Swasti Chemipharma has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Swasti Chemipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Swasti Chemipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.